TICKERNOMICS Sign up
Last Update: 2023-12-23 06:03:42
ELUTIA INC. ( ELUT )
1.95USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
ELUT
0.00%
SPY
30.72%
ELUT
0.00%
SPY
112.82%
ELUT
0.00%
SPY
201.04%
ELUT
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
45.74
68.54
0.13
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-1.35
1.09
-1.55
0.00
0.00
-3.95
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-53.45
46.37
-41.19
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
3.86
-56.17
-56.00
0.00
Other Earnings and Cash Flow Stats:
ELUTIA INC. ( ELUT ) Net Income TTM ($MM) is -33.07
ELUTIA INC. ( ELUT ) Operating Income TTM ($MM) is -19.65
ELUTIA INC. ( ELUT ) Owners' Earnings Annual ($MM) is 0.00
ELUTIA INC. ( ELUT ) Current Price to Owners' Earnings ratio is 0.00
ELUTIA INC. ( ELUT ) EBITDA TTM ($MM) is -15.88
ELUTIA INC. ( ELUT ) EBITDA Margin is -41.19%
Capital Allocation:
ELUTIA INC. ( ELUT ) has paid 0.00 dividends per share and bought back -9.328288 million shares in the past 12 months
ELUTIA INC. ( ELUT ) has increased its debt by 9.565 million USD in the last 12 months
Capital Structure:
ELUTIA INC. ( ELUT ) Interest-bearing Debt ($MM) as of last quarter is 37
ELUTIA INC. ( ELUT ) Annual Working Capital Investments ($MM) are -7
ELUTIA INC. ( ELUT ) Book Value ($MM) as of last quarter is -30
ELUTIA INC. ( ELUT ) Debt/Capital as of last quarter is -127%
Other Balance Sheet Stats:
ELUTIA INC. ( ELUT ) has 14 million in cash on hand as of last quarter
ELUTIA INC. ( ELUT ) has 44 million of liabilities due within 12 months, and long term debt 36 as of last quarter
ELUTIA INC. ( ELUT ) has 23 common shares outstanding as of last quarter
ELUTIA INC. ( ELUT ) has 0 million USD of preferred stock value
Academic Scores:
ELUTIA INC. ( ELUT ) Altman Z-Score is -4.57 as of last quarter
ELUTIA INC. ( ELUT ) Piotroski Score is 4.00 as of last quarter
Corporate Governance:
ELUTIA INC. ( ELUT ) largest shareholder is owning shares at 0.00 ($MM) value
Birchview Capital, Lp(an insider) Bought 10000 shares of ELUTIA INC. ( ELUT ) for the amount of $15900.00 on 2023-03-27
2.18% of ELUTIA INC. ( ELUT ) is held by insiders, and 70.44% is held by institutions
ELUTIA INC. ( ELUT ) went public on 2023-09-07
Other ELUTIA INC. ( ELUT ) financial metrics:
FCF:-17.11
Unlevered Free Cash Flow:0.00
EPS:-1.69
Operating Margin:-53.45
Gross Profit Margin:46.37
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:132.28
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About ELUTIA INC. ( ELUT ) :
Elutia Inc., a commercial-stage company, engages in developing and commercializing drug-eluting biomatrix technology to enhance surgical outcomes. It offers CanGaroo Envelope, which is used for the stabilization of implantable cardiac devices, such as pacemakers and defibrillators. The company also engages in the development of CanGaroo RM for delivery directly to the surgical site. In addition, it offers SimpliDerm Acellular Dermal Matrix used primarily in breast reconstruction following mastectomy. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.